FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171187650> ?p ?o ?g. }

• W2171187650 endingPage "862" @default.
• W2171187650 startingPage "854" @default.
• W2171187650 abstract "Radiation therapy (RT) is the most effective single modality for local control of Hodgkin lymphoma (HL) and an important component of therapy for many patients. These guidelines have been developed to address the use of RT in HL in the modern era of combined modality treatment. The role of reduced volumes and doses is addressed, integrating modern imaging with 3-dimensional (3D) planning and advanced techniques of treatment delivery. The previously applied extended field (EF) and original involved field (IF) techniques, which treated larger volumes based on nodal stations, have now been replaced by the use of limited volumes, based solely on detectable nodal (and extranodal extension) involvement at presentation, using contrast-enhanced computed tomography, positron emission tomography/computed tomography, magnetic resonance imaging, or a combination of these techniques. The International Commission on Radiation Units and Measurements concepts of gross tumor volume, clinical target volume, internal target volume, and planning target volume are used for defining the targeted volumes. Newer treatment techniques, including intensity modulated radiation therapy, breath-hold, image guided radiation therapy, and 4-dimensional imaging, should be implemented when their use is expected to decrease significantly the risk for normal tissue damage while still achieving the primary goal of local tumor control. The highly conformal involved node radiation therapy (INRT), recently introduced for patients for whom optimal imaging is available, is explained. A new concept, involved site radiation therapy (ISRT), is introduced as the standard conformal therapy for the scenario, commonly encountered, wherein optimal imaging is not available. There is increasing evidence that RT doses used in the past are higher than necessary for disease control in this era of combined modality therapy. The use of INRT and of lower doses in early-stage HL is supported by available data. Although the use of ISRT has not yet been validated in a formal study, it is more conservative than INRT, accounting for suboptimal information and appropriately designed for safe local disease control. The goal of modern smaller field radiation therapy is to reduce both treatment volume and treatment dose while maintaining efficacy and minimizing acute and late sequelae. This review is a consensus of the International Lymphoma Radiation Oncology Group (ILROG) Steering Committee regarding the modern approach to RT in the treatment of HL, outlining a new concept of ISRT in which reduced treatment volumes are planned for the effective control of involved sites of HL. Nodal and extranodal non-Hodgkin lymphomas (NHL) are covered separately by ILROG guidelines." @default.
• W2171187650 created "2016-06-24" @default.
• W2171187650 creator A5002120651 @default.
• W2171187650 creator A5005866115 @default.
• W2171187650 creator A5007588773 @default.
• W2171187650 creator A5022220719 @default.
• W2171187650 creator A5030811791 @default.
• W2171187650 creator A5055656652 @default.
• W2171187650 creator A5077236629 @default.
• W2171187650 creator A5079281059 @default.
• W2171187650 creator A5083034892 @default.
• W2171187650 creator A5083161940 @default.
• W2171187650 creator A5087045141 @default.
• W2171187650 date "2014-07-01" @default.
• W2171187650 modified "2023-09-30" @default.
• W2171187650 title "Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)" @default.
• W2171187650 cites W1523389686 @default.
• W2171187650 cites W1825210192 @default.
• W2171187650 cites W1843771850 @default.
• W2171187650 cites W1980374437 @default.
• W2171187650 cites W2000983363 @default.
• W2171187650 cites W2001744336 @default.
• W2171187650 cites W2005058208 @default.
• W2171187650 cites W2009236356 @default.
• W2171187650 cites W2025318905 @default.
• W2171187650 cites W2042228946 @default.
• W2171187650 cites W2072093919 @default.
• W2171187650 cites W2101472190 @default.
• W2171187650 cites W2122062060 @default.
• W2171187650 cites W2122654415 @default.
• W2171187650 cites W2140801657 @default.
• W2171187650 cites W2141164659 @default.
• W2171187650 cites W2153958355 @default.
• W2171187650 cites W2157830817 @default.
• W2171187650 cites W2165459402 @default.
• W2171187650 cites W2169043684 @default.
• W2171187650 cites W2570858546 @default.
• W2171187650 cites W2589822671 @default.
• W2171187650 cites W4243810912 @default.
• W2171187650 cites W4254965803 @default.
• W2171187650 doi "https://doi.org/10.1016/j.ijrobp.2013.05.005" @default.
• W2171187650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23790512" @default.
• W2171187650 hasPublicationYear "2014" @default.
• W2171187650 type Work @default.
• W2171187650 sameAs 2171187650 @default.
• W2171187650 citedByCount "431" @default.
• W2171187650 countsByYear W21711876502012 @default.
• W2171187650 countsByYear W21711876502013 @default.
• W2171187650 countsByYear W21711876502014 @default.
• W2171187650 countsByYear W21711876502015 @default.
• W2171187650 countsByYear W21711876502016 @default.
• W2171187650 countsByYear W21711876502017 @default.
• W2171187650 countsByYear W21711876502018 @default.
• W2171187650 countsByYear W21711876502019 @default.
• W2171187650 countsByYear W21711876502020 @default.
• W2171187650 countsByYear W21711876502021 @default.
• W2171187650 countsByYear W21711876502022 @default.
• W2171187650 countsByYear W21711876502023 @default.
• W2171187650 crossrefType "journal-article" @default.
• W2171187650 hasAuthorship W2171187650A5002120651 @default.
• W2171187650 hasAuthorship W2171187650A5005866115 @default.
• W2171187650 hasAuthorship W2171187650A5007588773 @default.
• W2171187650 hasAuthorship W2171187650A5022220719 @default.
• W2171187650 hasAuthorship W2171187650A5030811791 @default.
• W2171187650 hasAuthorship W2171187650A5055656652 @default.
• W2171187650 hasAuthorship W2171187650A5077236629 @default.
• W2171187650 hasAuthorship W2171187650A5079281059 @default.
• W2171187650 hasAuthorship W2171187650A5083034892 @default.
• W2171187650 hasAuthorship W2171187650A5083161940 @default.
• W2171187650 hasAuthorship W2171187650A5087045141 @default.
• W2171187650 hasConcept C126322002 @default.
• W2171187650 hasConcept C126838900 @default.
• W2171187650 hasConcept C143409427 @default.
• W2171187650 hasConcept C19527891 @default.
• W2171187650 hasConcept C201645570 @default.
• W2171187650 hasConcept C2775842073 @default.
• W2171187650 hasConcept C2778019345 @default.
• W2171187650 hasConcept C2779185275 @default.
• W2171187650 hasConcept C2779338263 @default.
• W2171187650 hasConcept C2989005 @default.
• W2171187650 hasConcept C509974204 @default.
• W2171187650 hasConcept C71924100 @default.
• W2171187650 hasConcept C9267231 @default.
• W2171187650 hasConceptScore W2171187650C126322002 @default.
• W2171187650 hasConceptScore W2171187650C126838900 @default.
• W2171187650 hasConceptScore W2171187650C143409427 @default.
• W2171187650 hasConceptScore W2171187650C19527891 @default.
• W2171187650 hasConceptScore W2171187650C201645570 @default.
• W2171187650 hasConceptScore W2171187650C2775842073 @default.
• W2171187650 hasConceptScore W2171187650C2778019345 @default.
• W2171187650 hasConceptScore W2171187650C2779185275 @default.
• W2171187650 hasConceptScore W2171187650C2779338263 @default.
• W2171187650 hasConceptScore W2171187650C2989005 @default.
• W2171187650 hasConceptScore W2171187650C509974204 @default.
• W2171187650 hasConceptScore W2171187650C71924100 @default.
• W2171187650 hasConceptScore W2171187650C9267231 @default.
• W2171187650 hasIssue "4" @default.
• W2171187650 hasLocation W21711876501 @default.

• next